database > company
DermTech International
Medical Devices & Tech
1020 Prospect Street, Suite 301
La Jolla, CA 92037-0068 USA
phone:858-450-4222
fax:858- 200-3877
Symbol Private
Founded 2004
Employees 12
          www.dermtechintl.com
Research Sector Medical Devices & Tech
Summary Description
Dermatology safety and efficacy testing.
Management
George B. Schwartz, CEO/President; Sherman Chang, PhD, Director, Molecular Biology; Jennifer Larson, Director, Business Development
Keywords
Dermatology, skin, testing, safety, dna, services, products

Comment | Printable Version | Modify profile Jan. 26, 2009

Description
DermTech International is an emerging biotechnology company specializing in the development and validation of molecular tests using specimens derived from the skin.
Products / Services
Dermtech International has developed the EGIR (Epidermal Genetic Information Retrieval ) for specific commercial applications in the fields of clinical research and medical diagnostics. The EGIR is a tool to correlate molecular changes in diseased skin with successful regimens in the treatment of skin disorders. The technique is also being studied for its potential in diagnosing and monitoring conditions that can be traced through molecular changes in the skin. Current research areas include early stage melanoma, prostrate cancer and psoriasis.
Technology / Differentiation
Dermtech International's EGIR is a proprietary, non-invasive technique for sampling the surface layers of the skin in order to generate individual genetic profiles for commercial applications in the clinical research and medical diagnostic fields.
Market / Customers
The scope of Dermtech International's products extends to four major areas of healthcare - Pharmaceutical research & development, Clinical research, Medical diagnostics & prognostics and Theranostics & treatment decision-making.
Status
The future plan is to provide a method for reliable sample collection by a broad range of medical personnel in an outpatient setting.


2010-09-08-718